Evidence map›Paper›PMID 32735183›Full record

ArticlePublic health reports (Washington, D.C. : 1974)

Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.

Suzanne M Marks, David W Dowdy, Nicolas A Menzies, Priya B Shete, Joshua A Salomon, Andrea Parriott, Sourya Shrestha, Jennifer Flood, Andrew N Hill

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trends in tuberculosis clinicians' adoption of short-course regimens for latent tuberculosis infection.Journal of clinical tuberculosis and other mycobacterial diseases · 2023
    Article
  2. Article
  3. Policy and Public Health : Reducing the Burden of Infectious Diseases.Public health reports (Washington, D.C. : 1974)
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Suzanne M Marks1242 Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.ORCID 0000-0003-3024-1940
David W Dowdy1466 Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Nicolas A Menzies1812 Prevention Policy Modeling Lab, Harvard University, Cambridge, MA, USA.
Priya B Shete8785 Consortium to Assess Prevention Economics, University of California at San Francisco, San Francisco, CA, USA.
Joshua A Salomon1812 Prevention Policy Modeling Lab, Harvard University, Cambridge, MA, USA.
Andrea Parriott8785 Consortium to Assess Prevention Economics, University of California at San Francisco, San Francisco, CA, USA.
Sourya Shrestha1466 Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Jennifer FloodTuberculosis Control Branch, California Department of Public Health, Richmond, CA, USA.
Andrew N Hill1242 Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

ECONOMIC ANALYSIS FOR PREVENTION OF DISEASE (EMPoD)U38PS004649 · PS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAHN, JAMES GUSTAVE · 2014 to 2015
$3.0M
ENHANCING MODELS OF HIV, VIRAL HEPATITIS, STIs, AND TUBERCULOSIS TO INFORM AND IMPROVE PUBLIC HEALTH IMPACTU38PS004646 · PS · EMORY UNIVERSITY · PI SULLIVAN, PATRICK · 2014 to 2015
$2.9M
Economic Modeling for HIV, Viral Hepatitis, STD, TB and School HealthU38PS004644 · PS · HARVARD SCHOOL OF PUBLIC HEALTH · PI SALOMON, JOSHUA A · 2014 to 2015
$2.9M
NCHHSTP CDC HHS U38 PS004644NCHHSTP CDC HHS U38 PS004646NCHHSTP CDC HHS U38 PS004649
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health PolicyModels, TheoreticalAntitubercular AgentsCost-Benefit AnalysisDisease EradicationHumansLatent TuberculosisMass ScreeningPractice Guidelines as TopicUnited StatesAntitubercular Agentscostcost-effectivelatent tuberculosis infection

Identifiers

PMID32735183
PMCPMC7407050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.